✦ LIBER ✦

30 Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the eurotransplant allocation system

✍ Scribed by M. Adler; J. Lerut; P. Starkel; H. Van Vlierberghe; R. Troisi; F. De Pauw; A. Fancello; G. Bonduel; E. De Gendt; P. Vereerstraeten; V. Donckier; O. Detry; J. Delwaide; P. Michielsen; T. Chapelle; J. Pirenne; F. Nevens

Book ID: 117374312
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 130 KB
Volume: 44
Category: Article
ISSN: 0168-8278
DOI: 10.1016/s0168-8278(06)80031-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Outcome of patients with hepatocellular

Outcome of patients with hepatocellular carcinoma listed for liver transplantation within the Eurotransplant allocation system

✍ Michael Adler; Filip De Pauw; Pierre Vereerstraeten; Agnese Fancello; Jan Lerut; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 155 KB 👁 1 views

Although hepatocellular carcinoma (HCC) has become a recognized indication for liver transplantation, the rules governing priority and access to the waiting list are not well defined. Patient-and tumor-related variables were evaluated in 226 patients listed primarily for HCC in Belgium, a region whe

662 OUTCOME OF PATIENTS WITH HEPATOCELLU

662 OUTCOME OF PATIENTS WITH HEPATOCELLULAR CARCINOMA LISTED FOR LIVER TRANSPLANTATION BEFORE AND AFTER THE MELD-BASED ALLOCATION SYSTEM WITHIN EUROTRANSPLANT A BELGIAN MULTICENTRE RETROSPECTIVE STUDY

✍ B. Vos; S. Rogge; F. Nevens; J. Pirenne; J. Lerut; O. Ciccarelli; H. Van Vlierbe 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Use of Marginal Donors for Liver Transpl

Use of Marginal Donors for Liver Transplantation: A Single-Center Experience Within the Eurotransplant Patient-Driven Allocation System

✍ V. Lucidi; A.C. Lemyé; L. Baire; A. Buggenhout; A.D. Hoang; P. Loi; F. Mboti; D. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Drop-out rates of patients with hepatoce

Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: Outcome with chemoembolization

✍ Yamini K. Maddala; Linda Stadheim; James C. Andrews; Lawrence J. Burgart; Charle 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 1 views

Patients with hepatocellular carcinoma (HCC) are assigned model for end stage liver disease (MELD) scores to provide access to liver transplantation (LT). An equitable policy would equate HCC progression beyond acceptable transplantation criteria with death on the waiting list. However, limited info

Outcomes after liver transplantation for

Outcomes after liver transplantation for patients with hepatocellular carcinoma and a low risk of dropout from the transplant waiting list

✍ Mehta, Neil; Dodge, Jennifer L.; Roberts, John Paul; Hirose, Ryutaro; Yao, Franc 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 124 KB

Tools for monitoring patients with hepat

Tools for monitoring patients with hepatocellular carcinoma on the waiting list and after liver transplantation

✍ Norman Kneteman; Tito Livraghi; David Madoff; Eduardo de Santibañez; Michael Kew 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

For patients who are initially being listed for liver transplantation and for patients who are seeking to retain their active status on the wait list, the first step in the diagnostic consideration of hepatocellular carcinoma (HCC) is the accurate identification and staging of the tumors. Advances i